(Reuters) - Measles cases rose 20% last year, driven by a lack of vaccine coverage in the world's poorest countries and those ...

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, ...

The Nova 301 Trial is looking to recruit approximately 25,000 people globally to see if an investigational mRNA vaccine can ...

That can result in permanent changes in personality and intellectual development. The measles vaccine is highly effective but ...

The day after the election, some celebrated Trump's win and RFK Jr.'s potential role as a public health decision-maker. Why?

Global measles cases surged by more than 20% to an estimated 10.3 million last year, the World Health Organization and the US ...

Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

The data from the CDC's National Immunization Survey estimates that 37.6% of Americans ages 65 and older had gotten a shot of ...

A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...

Measles infections soared by a fifth last year to over 10 million cases globally, revealing alarming gaps in vaccine coverage ...